Cargando…

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Vaccines that efficiently target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent for coronavirus disease (COVID-19), are the best means for controlling viral spread. This study evaluated the efficacy of the COVID-19 vaccine S-268019-b, which comprises the recombin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Homma, Tomoyuki, Nagata, Noriyo, Hashimoto, Masayuki, Iwata-Yoshikawa, Naoko, Seki, Naomi M., Shiwa-Sudo, Nozomi, Ainai, Akira, Dohi, Keiji, Nikaido, Eiji, Mukai, Akiko, Ukai, Yuuta, Nakagawa, Takayuki, Shimo, Yusuke, Maeda, Hiroki, Shirai, Seiki, Aoki, Miwa, Sonoyama, Takuhiro, Sato, Mamoru, Fumoto, Masataka, Nagira, Morio, Nakata, Fumihisa, Hashiguchi, Takao, Suzuki, Tadaki, Omoto, Shinya, Hasegawa, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718471/ https://www.ncbi.nlm.nih.gov/pubmed/36460696 http://dx.doi.org/10.1038/s41598-022-25418-5

Ejemplares similares

Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
por: Hashimoto, Masayuki, et al.
Publicado: (2022)

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

Safety and immunogenicity of a booster dose of S-268019-b: Interim findings of a Phase 3, open-label clinical study in Japan
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques
por: Hashimoto, Masayuki, et al.
Publicado: (2022)

Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study
por: Shinkai, Masaharu, et al.
Publicado: (2022)

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
por: Hemmi, Takuya, et al.
Publicado: (2022)

High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
por: Fujisawa, Mizuki, et al.
Publicado: (2023)

Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings
por: Iwata, Satoshi, et al.
Publicado: (2022)

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
por: Miyamoto, Sho, et al.
Publicado: (2023)

Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection
por: Kawaguchi, Akira, et al.
Publicado: (2017)

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
por: Shiwa-Sudo, Nozomi, et al.
Publicado: (2023)

2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein
por: Kawamura, Tatsuro, et al.
Publicado: (2023)

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
por: Ueno, Mikako, et al.
Publicado: (2022)

Safety, Tolerability, and Pharmacokinetics of the Novel Antiviral Agent Ensitrelvir Fumaric Acid, a SARS-CoV-2 3CL Protease Inhibitor, in Healthy Adults
por: Shimizu, Ryosuke, et al.
Publicado: (2022)

A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations
por: Shimizu, Ryosuke, et al.
Publicado: (2023)

cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue
por: Takaki, Hiromi, et al.
Publicado: (2017)

Suppression of Peritoneal Fibrosis by Sonoporation of Hepatocyte Growth Factor Gene-Encoding Plasmid DNA in Mice
por: Nishimura, Koyo, et al.
Publicado: (2021)

Evaluation of the Drug–Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults
por: Shimizu, Ryosuke, et al.
Publicado: (2023)

164. in Vitro Antibacterial Activity of Cefiderocol Against Non-fermenter Clinical Strains Collected in North America and Europe from Multinational Surveillance Studies SIDERO-WT-2014–2018
por: Ukai, Yuuta, et al.
Publicado: (2020)

Microarray-based gene expression analysis combined with laser capture microdissection is beneficial in investigating the modes of action of ocular toxicity
por: Shirai, Makoto, et al.
Publicado: (2021)

A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component
por: Yoshioka, Yuya, et al.
Publicado: (2023)

Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
por: Ainai, Akira, et al.
Publicado: (2013)

Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
por: Nomura, Takushi, et al.
Publicado: (2021)

549. Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial
por: Tsuge, Yuko, et al.
Publicado: (2023)

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
por: Onodera, Taishi, et al.
Publicado: (2021)

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
por: Miyamoto, Sho, et al.
Publicado: (2022)

The co-existence of a myxoid liposarcoma and leiomyoma in the same ovarian mass of a dog
por: SHIWA, Nozomi, et al.
Publicado: (2015)

Cervical ganglioneuroblastoma in a new born Japanese Black calf
por: PARK, Chun-Ho, et al.
Publicado: (2018)

Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8(+) T cell responses
por: Ishii, Hiroshi, et al.
Publicado: (2022)

1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections
por: Matsunaga, Yuko, et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

548. Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection
por: Tsuge, Yuko, et al.
Publicado: (2023)

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells
por: Nagira, Yoji, et al.
Publicado: (2023)

Histological scoring system for subchondral bone changes in murine models of joint aging and osteoarthritis
por: Nagira, Keita, et al.
Publicado: (2020)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers()
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

A Metabolomic Signature of Acute Caloric Restriction
por: Collet, Tinh-Hai, et al.
Publicado: (2017)

Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
por: Kotani, Osamu, et al.
Publicado: (2021)

The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model
por: Kataoka, Chikako, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g6u6572t633l2f3mefb8niidnm